The B.1.1.7 British COVID variant is sweeping across the United States. How will vaccines fare?

Credit: Little Village
Credit: Little Village

The B.1.1.7 variant, first spotted in the UK, is not only more easily transmitted, but it also appears to be more deadly. Dr. Anthony Fauci warned about it [March 19] in a White House coronavirus update.

It was first spotted in Colorado at the end of December, said Fauci, the director of the National Institute of Allergy and Infectious Diseases and the chief medical adviser to President Biden.

“Since then it has been detected in 50 jurisdictions in the United States, and likely accounts now for about 20 to 30% of the infections in this country. And that number is growing,” Fauci said.

Fauci pointed to one study showing a 64% increased risk of death for people infected with B.1.1.7 compared to those infected with the older, so-called wild-type variant. 

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

Real-life use of the Pfizer/BioNTech and Moderna vaccines indicate that while the B.1.1.7 variant can elude, somewhat, the immune response prompted by immunization, it’s not enough to make the vaccines any less effective in protecting people. That’s because the vaccines cause a broad immune response so that even if it’s a little weakened, it’s still powerful enough to prevent serious disease and death.

Read the original post

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
skin microbiome x final

Infographic: Could gut bacteria help us diagnose and treat diseases? This is on the horizon thanks to CRISPR gene editing

Humans are never alone. Even in a room devoid of other people, they are always in the company of billions ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.